Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity.
Issue Date
2020-02-07Keywords
ERKJNK
MAPK
CANCER
combination therapy
drug resistance
epigenetics
metabolism
p38
Metadata
Show full item recordJournal
International journal of molecular sciencesDOI
10.3390/ijms21031102PubMed ID
32046099Item Type
ArticleOther
Language
enEISSN
1422-0067ae974a485f413a2113503eed53cd6c53
10.3390/ijms21031102
Scopus Count
Collections
Related articles
- Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
- Authors: Rovida E, Stecca B
- Issue date: 2015 Dec
- Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
- Authors: Alexander LD, Cui XL, Falck JR, Douglas JG
- Issue date: 2001 Jun
- Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
- Authors: Otto KB, Acharya SS, Robinson VL
- Issue date: 2012 Jul-Aug
- Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
- Authors: Leo V, Stefanachi A, Nacci C, Leonetti F, de Candia M, Carotti A, Altomare CD, Montagnani M, Cellamare S
- Issue date: 2015 Oct
- p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
- Authors: Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY
- Issue date: 2007 May 1